Indoor air quality (IAQ) has a substantial impact on public health. Since the beginning of the COVID-19 pandemic, more employees have worked remotely from home to minimize in-person contacts. This pilot study aims to measure the difference in workplace IAQ before and during the pandemic and its impact on employees’ health. The levels of fine particulate matter (PM_2.5) and total volatile organic chemicals (tVOC) were measured in the employees’ offices before the COVID-19 pandemic and at homes while working from home during the pandemic using Foobot air monitors. The frequencies of six sick building syndrome (SBS) symptoms were evaluated at each period of monitoring. The result showed PM_2.5 levels in households while working from home were significantly higher than in offices while working at the office for all participants (p < 0.05). The PM_2.5 levels in all households exceeded the health-based annual mean standard (12 µg/m³), whereas 90% of offices were in compliance. The tVOC levels were all below the standard (500 µg/m³). We also found a higher frequency of SBS symptoms were observed while working from home as the IAQ was worse at home. This study suggested that working from home might have a detrimental health impact due to poor IAQ and providing interventions to remote employees should be considered.

Background: In Mexico, the COVID-19 pandemic led to preventative measures such as confinement and social interaction limitations that paradoxically may have aggravated healthcare access disparities for pregnant women and accentuated health system weaknesses addressing high-risk patients’ pregnancies. Our objective is to estimate the maternal mortality ratio in 1 year and analyze the clinical course of pregnant women hospitalized due to acute respiratory distress syndrome and COVID-19. Methods: A retrospective surveillance study of the national maternal mortality was performed from February 2020–February 2021 in Mexico related to COVID-19 cases in pregnant women, including their outcomes. Comparisons were made between patients who died and those who survived to identify prognostic factors and underlying health conditions distribution. Results: Maternal Mortality Ratio increased by 56.8% in the studied period, confirmed COVID-19 was the cause of 22.93% of cases. Additionally, unconfirmed cases represented 4.5% of all maternal deaths. Among hospitalized pregnant women with Acute Respiratory Distress Syndrome consistent with COVID-19, smoking and cardiovascular diseases were more common among patients who faced a fatal outcome. They were also more common in the age group of < 19 or > 38. In addition, pneumonia was associated with asthma and immune impairment, while diabetes and increased BMI increased the odds for death (Odds Ratio 2.30 and 1.70, respectively). Conclusions: Maternal Mortality Ratio in Mexico increased over 60% in 1 year during the pandemic; COVID-19 was linked to 25.4% of maternal deaths in the studied period. Lethality among pregnant women with a diagnosis of COVID-19 was 2.8%, and while asthma and immune impairment increased propensity for developing pneumonia, obesity and diabetes increased the odds for in-hospital death. Measures are needed to improve access to coordinated well-organized healthcare to reduce maternal deaths related to COVID-19 and pandemic collateral effects.

Few studies have investigated household interventions to enhance indoor air quality (IAQ) and health outcomes in relatively low-income communities. This study aims to examine the impact of the combined intervention with asthma education and air purifier on IAQ and health outcomes in the US-Mexico border area. An intervention study conducted in McAllen, Texas, between June and November 2019 included 16 households having children with asthma. The particulate matter (PM_2.5) levels were monitored in the bedroom, kitchen, and living room to measure the IAQ for 7 days before and after the intervention, respectively. Multiple surveys were applied to evaluate changes in children's health outcomes. The mean PM_2.5 levels in each place were significantly improved. Overall, they significantly decreased by 1.91 μg/m³ on average (p<0.05). All surveys showed better health outcomes; particularly, quality of life for children was significantly improved (p<0.05). This pilot study suggests that the combined household intervention might improve IAQ in households and health outcomes for children with asthma and reduce health disparities in low-income communities. Future large-scale studies are needed to verify the effectiveness of this household intervention to improve IAQ and asthma management.